A consortium of the five University of California medical campuses at Davis, Irvine, Los Angeles, San Diego and San Francisco has been awarded a $12 million grant and designated as a Center for Accelerated Innovations, one of three in the country, by the National Heart, Lung and Blood Institute. The award, among the first of its kind from the institute, recognizes UC's potential to translate its leading-edge discoveries into innovative products that benefit patients.
The University of California Center for Accelerated Innovation (UC CAI) will leverage the expertise and resources of the system’s medical center campuses and use industrial product-development practices to incubate technologies with high commercial potential. The five campuses accounted for 7 percent of NHLBI’s fiscal year 2012 grant funding, providing a rich research base to support a diverse pipeline of diagnostics, devices, therapeutics and tools for heart, lung and blood diseases.
Administration of the UC CAI will be based at UCLA.
